.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Healthtrust
US Army
AstraZeneca
Moodys
QuintilesIMS
Novartis
Accenture
Johnson and Johnson

Generated: June 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,795,751

« Back to Dashboard

Claims for Patent: 4,795,751

Title: 5-substituted-6,8-difluoroquinolines useful as antibacterial agents
Abstract:The present invention relates to a quinoline derivative of the formula ##STR1## wherein Z is an amino group or a halogen atom, R.sub.1 is a hydrogen atom or a methyl or ethyl group, R.sub.2 is a hydrogen atom or a methyl or fluoromethyl group, R.sub.3 and R.sub.4 are the same or different and each represents a hydrogen atom or a methyl group, and n is 1 or 2; and esters thereof and salts thereof and processes for preparation thereof. These compounds show excellent antibacterial activity and are useful antibacterial agents.
Inventor(s): Matsumoto; Jun-ichi (Ikoma, JP), Miyamoto; Teruyuki (Sakai, JP), Egawa; Hiroshi (Toyonaka, JP), Nakamura; Shinichi (Takatsuki, JP)
Assignee: Dainippon Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:06/928,297
Patent Claims: 1. A member selected from the group consisting of

(1) a compound of the formula ##STR55## wherein R.sub.1 is a hydrogen atom or a methyl group, R.sub.2 is a methyl or fluoromethyl group, and R.sub.3 is a hydrogen atom or a methyl group,

(2) a pharmaceutically acceptable ester thereof, and

(3) a pharmaceutically acceptable salt of said compound (1) or said ester (2).

2. 5- Amino-1-cyclopropyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-o xoquinoline-3-carboxylic acid or a pharmaceutically acceptable acid addition salt thereof.

3. 5-Amino-1-cyclopropy l-6,8-difluoro-7-(3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3- carboxylic acid or a pharmaceutically acceptable acid addition salt thereof.

4. An antibacterial composition which comprises an antibacterially effective amount of a compound, ester or salt there of as defined in claim 1 and a pharmaceutically acceptable carrier therefor.

5. A method for the treatment of a bacterial infectious disease which comprises administering an antibacterially effective amount of a compound, ester or salt thereof as defined in claim 1 to a warm-blooded animal.

6. A member selected from the group consisting of

(1) a compound of the formula ##STR56## wherein R.sub.1 is a hydrogen atom or a methyl group, R.sub.2 is a hydrogen atom or a methyl or fluoromethyl group, and R.sub.3 is a hydrogen atom or a methyl group,

(2) a pharmaceutically acceptale ester thereof, and

(3) a pharmaceutically acceptable salt of said compound (1) or said ester (2).

7. 1- Cyclopropyl-5,6,8-trifluoro-7-(1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3- carboxylic acid or a pharmaceutically acceptable acid addition salt thereof.

8. 1-Cyclopropyl-5,6,8-trifluoro-7-(4-methyl-1-piperazinyl)-1,4-dihydro-4-o xoquinoline-3-carboxylic acid or a pharmaceutically acceptable acid addition salt thereof.

9. 1-Cyclopropyl-5,6,8- trifluoro-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxyli c acid or a pharmaceutically acceptable acid addition salt thereof.

10. An antibacterial composition which comprises an antibacterially effective amount of a compound, ester or salt thereof as defined in claim 6 and a pharmaceutically acceptable carrier therefor.

11. A method for the treatment of a bacterial infectious disease which comprises administering an antibacterially effective amount of a compound, ester or salt thereof as defined in claim 6 to a warm-blooded animal.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Accenture
Johnson and Johnson
QuintilesIMS
McKinsey
Baxter
Harvard Business School
Dow
Healthtrust
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot